Drawing for M MALLINCKRODT

USPTO serial 85646928

M MALLINCKRODT

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
RIRIE, VERNA BETH
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with M MALLINCKRODT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Active chemical ingredients for use in the manufacture of pharmaceuticals for treating pain, cough and upper respiratory symptoms, opioid addiction, behavioral disorders, diabetes, and prostate cancer; Excipients and chemical additives for use in the manufacture of pharmaceuticals and food; Chemicals for use in the manufacture of radiopharmaceuticalsACTIVE
005Pharmaceutical preparations for the treatment of pain, cough and upper respiratory symptoms, opioid addiction, insomnia, depression, and behavioral disorders; contrast media for use in medical imaging procedures; radiopharmaceutical preparations for use in nuclear medicine; Pharmaceutical kits for making radiopharmaceutical diagnostic preparations; syringes sold filled with saline solutionACTIVE
010Non-invasive power injectors used for subcutaneous injection of medicine and imaging solutions for medical imaging procedures and component parts therefor; Medical apparatus for warming contrast media; Medical generators for use in the production and transportation of nuclear medicine and component parts therefor; Radioaerosol generators, namely, nebulizers for administering radioactive medicine and imaging solutions in gaseous form for medical imaging procedures and component parts therefor; Elution shields, namely, nuclear medicine radiation apparatus for collection of sodium-pertechnetate from Mo99/ Tc99m generators and radiation shielding; Medical imaging apparatus and instruments in the field of urology, and component parts thereforACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Feb 18, 2014MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 17, 2014ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 16, 2013DOCKASSIGNED TO EXAMINER
Jul 16, 2013NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 21, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 21, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 1, 2013NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 15, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 10, 2013ALIEASSIGNED TO LIE
Mar 20, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Mar 20, 2013XAECEXAMINER'S AMENDMENT ENTERED
Mar 20, 2013GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 20, 2013GNEAEXAMINERS AMENDMENT E-MAILED
Mar 20, 2013CNEAEXAMINERS AMENDMENT -WRITTEN
Mar 19, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Mar 18, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 18, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 25, 2012GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 25, 2012GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 25, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 25, 2012DOCKASSIGNED TO EXAMINER
Jun 19, 2012MDSCNOTICE OF DESIGN SEARCH CODE MAILED
Jun 18, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 12, 2012NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance